Aus dem Englischen übersetzt-

During the past decade, Centre Hospitalier de Luxembourg conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 7 clinical trials were completed, i.e. on average, 36.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Luxembourg" #1 sponsor was "Luxembourg Institute of Health" with 4 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 3 trials sponsored, "Rigshospitalet, Denmark" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Luxembourg" #1 collaborator was "Centre Hospitalier du Luxembourg" with 7 trials as a collaborator, "Integrated Biobank of Luxembourg" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials as a collaborator and "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator. Other collaborators include 89 different institutions and companies that were collaborators in the rest 99 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Luxembourg" are "AIDS" (2 trials), "Acute Myeloid Leukemia" (2 trials), "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials), "Acidosis, Lactic" (1 trials) and "Allergy" (1 trials). Many other conditions were trialed in "Centre Hospitalier de Luxembourg" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Luxembourg" are "Drug" (16 trials), "Device" (5 trials), "Procedure" (5 trials), "Other" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Vinorelbine" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials) and "AG-120" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Luxembourg" are 36 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are 12 active trials in "Centre Hospitalier de Luxembourg". 1 are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Centre Hospitalier de Luxembourg, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Luxembourg, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".